Is the combined auriculotherapy approach superior to magneto-auriculotherapy alone in aging males with lower urinary tract symptoms? A randomized controlled trial

被引:6
作者
Suen, Lorna K. P. [1 ]
Yeh, Chao Hsing [2 ]
Yeung, Simon K. W. [1 ]
Yeung, Jerry W. F. [1 ]
机构
[1] Hong Kong Polytech Univ, Sch Nursing, HungHom, Hong Kong, Peoples R China
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA
关键词
Aging male; lower urinary tract symptoms; randomized controlled trial; elder; auriculotherapy; laser; LOW-BACK-PAIN; COMBINATION THERAPY; ALPHA-BLOCKERS; MEN; IMPACT; ELDERS;
D O I
10.1080/13685538.2018.1542673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The negative impact of lower urinary tract symptoms (LUTS) on affected males is substantial. This study aims to assess whether a combined auriculotherapy (AT) using laser AT (LAT) and magneto-AT (MAT) is more effective than using MAT alone or placebo for managing LUTS of aging males.Methods: A randomized controlled, double-blinded trial was conducted. Sixty-two aging males with moderate or severe LUTS symptoms were randomly allocated into groups: Group 1, placebo LAT plus placebo MAT (n = 20); Group 2, combined AT approach using LAT plus MAT (n = 20); and Group 3, placebo LAT followed by MAT (n = 22). Six ear acupoints assumed to be suitable for alleviating LUTS were used. The total treatment period was 4 weeks, with follow-up visits till 3 months. Generalized estimating equations model was used for the examination of the interactions among the groups over time.Results: A combined AT approach exhibited a stronger treatment effect in relieving voiding problems, improving the peak urinary flow rate, and reducing the post-void residual urine than the placebo group or MAT alone.Conclusions: This study demonstrates that the AT protocol used in this study for aging males with LUTS is feasible and can be adopted in future study of increased scale.
引用
收藏
页码:544 / 555
页数:12
相关论文
共 55 条
  • [1] Abbate S., 2015, CHINESE AURICULAR AC
  • [2] Administration of daily 5mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia
    Amano, Toshiyasu
    Earle, Carolyn
    Imao, Tetsuya
    Matsumoto, Yuki
    Kishikage, Takahiro
    [J]. AGING MALE, 2018, 21 (01) : 77 - 82
  • [3] [Anonymous], 2014, HEAR HERE MULTIMEDIA
  • [4] [Anonymous], 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/984763
  • [5] Using generalized estimating equations and extensions in randomized trials with missing longitudinal patient reported outcome data
    Bell, Melanie L.
    Horton, Nicholas J.
    Dhillon, Haryana M.
    Bray, Victoria J.
    Vardy, Janette
    [J]. PSYCHO-ONCOLOGY, 2018, 27 (09) : 2125 - 2131
  • [6] Calogero AE., 2018, AGING MALE, V29, P1
  • [7] Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction
    Calogero, Aldo E.
    Burgio, Giovanni
    Condorelli, Rosita A.
    Cannarella, Rossella
    La Vignera, Sandro
    [J]. AGING MALE, 2019, 22 (01) : 12 - 19
  • [8] Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms
    Choi, Edmond P. H.
    Lam, Cindy L. K.
    Chin, Weng-Yee
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [9] Factor structure of a Cantonese-version Pittsburgh Sleep Quality Index
    Chong, Alice M. L.
    Cheung, Chau-Kiu
    [J]. SLEEP AND BIOLOGICAL RHYTHMS, 2012, 10 (02) : 118 - 125
  • [10] Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?
    Cindolo, Luca
    Pirozzi, Luisella
    Sountoulides, Petros
    Fanizza, Caterina
    Romero, Marilena
    Castellan, Pietro
    Antonelli, Alessandro
    Simeone, Claudio
    Tubaro, Andrea
    de Nunzio, Cosimo
    Schips, Luigi
    [J]. BMC UROLOGY, 2015, 15